Type 2 diabetes trials in Latvia

2 of 3 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Where

  Daugavpils, Jelgava, Ogre, Riga, Siguldas Pagasts, Ventspils

  Age

  18 years and over

  People

  11,800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07064473 · EU 2025-521188-11-00
• No phaseEnrolling by invitation
  Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study

  Where

  Riga

  Age

  25 years to 80 years

  People

  66

  Run by

  Pauls Stradins Clinical University Hospital

  See details and how to joinNCT06846138